blood

Increased Likelihood Predicted of Stem Cell Treatments in Ones Lifetime

April 3, 2012

While earlier studies demonstrated that the likelihood of using stem cells for treatment are 1 in 217 during a patient’s lifetime, more recent studies are predicting that as many as 1 in 100 Americans will be treated with stem cells before the age of 70 reports Dr Rhonda Verzai in the Daytona Beach News-Journal. Dr. [...]

Read the full article →

Umbilical Cord Blood Transplantation Milestones Reached

March 7, 2012

  Since the first human cord blood transplant, performed in 1988, cord blood banks have been established worldwide for collection and cryopreservation of cord blood for hematopoietic stem cell transplantation. Umbilical cord blood (UCB) has now become one of the most commonly used source of hematopoietic stem cells for transplantation for one’s personal use (autologous) and matched unrelated recipients (allogeneic). [...]

Read the full article →

Rapid Expansion of Human Hematopoietic Stem Cells

March 6, 2012

Clinical hematopoietic transplantation outcomes are strongly correlated with the numbers of cells infused.  While the stem cells from a single cord blood unit may be enough to treat small children, it often takes multiple cord blood units to treat adults.  Thus researchers have been looking into ways to culture cord blood in vivo to expand [...]

Read the full article →

Cord Blood and Tissue Banking From Kit to Lab by FamilyCord

February 20, 2012

Have you ever wondered about the entire process of cord blood collection, from enrollment, to kit to lab? Check out this fun animated video for a great take on how cord blood and tissue banking works.

Read the full article →

Why consider Family Cord Blood Banking?

January 31, 2012

Families ask us why use family cord blood banking (also known as private cord blood banking)? Those who store their stem cells at a family cord blood bank realize the advantage of having stem cells saved for their child (autologous transplants) as well as having a much higher chance of having a stem cell match [...]

Read the full article →

New Study Shows Cord Blood Stem Cells May Treat Type 1 Diabetes

January 12, 2012

A newly published clinical trial result reports treating Type 1 diabetics T-Cells with umbilical cord blood stem cells helped restart pancreatic function and insulin production.  The process is called “re-education” as the newly introduced T-Cells improved the behavior of the patients own T-Cells. The study recruited 15 Type 1 diabetic patients, twelve of which had [...]

Read the full article →

First Cord Blood ‘Product’ Approved by FDA

November 11, 2011

HEMACORD(TM), a umbilical cord blood product, has been approved by the Food and Drug Administration for allogeneic hematopoietic stem cell transplantation, the first such approval of a stem cell product in the world. “The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders,” said [...]

Read the full article →

A FamilyCord Client Success Story

November 4, 2011

DALLAS (CBSDFW.COM) – Even before a baby is born, parents face a major decision, whether or not to save their child’s umbilical cord blood. Cord blood holds a wealth of stem cells that can be used later to cure fatal diseases. But some blood banks are letting patients down, and even putting children’s lives at [...]

Read the full article →

New Heart Therapies Using Cord Blood

October 22, 2011

A new study published by Stem Cell Reviews & Reports shows stem cells from umbilical cord blood can be utilized to treat damaged heart muscles. Over the past 18 years umbilical cord blood has been used for blood and immune system disorders.  The new possibilities for their use in a wider variety of health conditions, genetic [...]

Read the full article →

Umbilical cord blood: a source of pluripotent stem cells for regenerative medicine

August 17, 2011

There are estimates that that almost 1 in 3 individuals in the United States might benefit from regenerative medicine therapy. Unfortunately, embryonic stem (ES) cell therapies are currently limited in meeting this demand due to ethical, political, biological and regulatory hurdles. Thus, the future growth of regenerative medicine in the clinic will depend upon the [...]

Read the full article →

← Previous Entries